| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0095 | 0.9 |